Director, See remarks, 10% Owner · Ginkgo Bioworks Holdings, Inc. · Class A Common Stock
Side
SELL
Value
$91K
Shares
13.2K
Price
$6.93
Executed
Apr 8, 2026
Disclosed
Apr 10, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 8 executedApr 10, 2026 disclosed
DNA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Shetty Reshma P. filed this Form 4 reporting a open-market sale of DNA on Apr 8, 2026. It became public on Apr 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, See remarks, 10% Owner
Shetty Reshma P.cik:0001873523
Issuer
Ginkgo Bioworks Holdings, Inc.cik:0001830214
Revision history · 0
No field has changed since this record was first ingested.
